On average, a life is lost every hour of the day due to lack of ​organ transplants.

Drug development takes too long (10 years), costs too much ($2B), and targets symptoms rather than diseases.​

Animal studies are ineffective for human drug & cosmetic development and leads to the death of millions of innocent animals.

At BICO, we create the future of life-saving treatments by reducing the world's organ shortage and speeding up drug development.

On average, a life is lost every hour of the day due to lack of ​organ transplants.

Drug development takes too long (10 years), costs too much ($2B), and targets symptoms rather than diseases.​

Animal studies are ineffective for drug & cosmetic development and leads to the death of millions of innocent animals.

At BICO, we create the future of life-saving treatments by reducing the world's organ shortage and speeding up drug development.

Accessible Life Science Solutions

BICO reduces the organ shortage and speeds up drug development by providing accessible life science solutions that combine biology and technology, fundamentally shifting the global healthcare industry.
Using a combination of robotics, artificial intelligence, advanced genomics, and 3D bioprinting, our innovative technologies enable researchers and practitioners in the life sciences to conduct cell line development, perform high-throughput drug screening and diagnostics, and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries.
BICO by Numbers
  • Net sales Q1 2022
    0 MSEK
  • Organic growth Q1 2022
    0 %
  • Employees
    0 +
  • Instruments in the field
    0 +
  • Publications
    0 +
  • Countries
    0 +
Business Areas

Enabling the future of life-saving treatments through bioprinting of tissues and organs.

Accelerating development and manufacturing of diagnostic and bioanalysis test platforms.

Providing user-friendly instruments to bring efficiency and speed to multiple application areas.

Business Areas

Enabling the future of life-saving treatments through bioprinting of tissues and organs.

Accelerating development and manufacturing of diagnostic and bioanalysis test platforms.

User-friendly instruments to bringing efficiency and speed to multiple application areas.

Synergies Enabling Automated Workflows